Birmingham Capital Management CO Inc/Al Abb Vie Inc. Transaction History

Birmingham Capital Management CO Inc/Al

$274 Million
Q3 2024

A detailed history of Birmingham Capital Management CO Inc/Al transactions in Abb Vie Inc. stock. As of the latest transaction made, Birmingham Capital Management CO Inc/Al holds 30,622 shares of ABBV stock, worth $5.49 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

30,622

Previous 29,722 3.03%

Holding current value

$5.49 Million

Previous $5.1 Million 18.64%

% of portfolio

2.21%

Previous 2.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 10, 2024	BUY	$163.84 - $199.33 $5.02 Million - $6.1 Million	30,622 New	30,622 $6.05 Million
Q2 2024 Aug 28, 2024	BUY	$154.79 - $180.76 $4.6 Million - $5.37 Million	29,722 New	29,722 $5.1 Million
Q1 2024 May 29, 2024	BUY	$159.82 - $182.1 $4.75 Million - $5.41 Million	29,722 New	29,722 $5.41 Million
Q4 2023 Feb 20, 2024	SELL	$137.6 - $154.97 $11,008 - $12,397	-80 Reduced 0.26%	30,322 $4.7 Million
Q3 2023 Dec 13, 2023	BUY	$133.59 - $154.65 $96,852 - $112,121	725 Added 2.44%	30,402 $4.53 Million
Q2 2023 Sep 19, 2023	SELL	$132.51 - $164.9 $175,310 - $218,162	-1,323 Reduced 4.27%	29,677 $4 Million
Q1 2023 May 22, 2023	BUY	$144.61 - $166.54 $2,892 - $3,330	20 Added 0.06%	31,000 $4.94 Million
Q3 2022 Dec 02, 2022	BUY	$134.21 - $153.93 $67,105 - $76,965	500 Added 1.64%	30,980 $4.16 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $98,984 - $122,812	-750 Reduced 2.4%	30,480 $4.94 Million
Q3 2021 Dec 20, 2021	SELL	$106.4 - $120.78 $85,120 - $96,624	-800 Reduced 2.5%	31,230 $3.37 Million
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $20,460 - $22,524	-200 Reduced 0.62%	32,030 $3.47 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $83,709 - $113,016	1,040 Added 3.33%	32,230 $3.45 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $116,837 - $137,128	1,360 Added 4.56%	31,190 $2.73 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $40,353 - $53,999	550 Added 1.88%	29,830 $2.93 Million
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $64,500 - $97,790	-1,000 Reduced 3.3%	29,280 $2.23 Million
Q4 2019 Feb 03, 2020	SELL	$72.13 - $90.25 $61,310 - $76,712	-850 Reduced 2.73%	30,280 $2.68 Million
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $119,662 - $143,868	1,900 Added 6.5%	31,130 $2.36 Million
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $3,942 - $5,038	60 Added 0.21%	29,230 $2.13 Million
Q1 2019 Apr 25, 2019	BUY	$77.14 - $90.79 $104,139 - $122,566	1,350 Added 4.85%	29,170 $2.35 Million
Q4 2018 Jan 30, 2019	BUY	$77.85 - $96.01 $13,390 - $16,513	172 Added 0.62%	27,820 $2.57 Million
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $27,603 - $36,963	-300 Reduced 1.07%	27,648 $2.62 Million
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $2.5 Million - $2.74 Million	27,948	27,948 $2.7 Million

Others Institutions Holding ABBV

# of Institutions

3,854

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birmingham Capital Management CO Inc/Al, based on Form 13F filings with the SEC.

News

Stay updated on Birmingham Capital Management CO Inc/Al with notifications on news.

Account

Birmingham Capital Management CO Inc/Al Abb Vie Inc. Transaction History